Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Neural Implants Market Growth Potential: How Will Market Size Shift Through 2030?
The neural implants market has observed significant growth recently. Its value is projected to rise from $5.91 billion in 2025 to $6.53 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.4%. Historically, this expansion has been driven by factors such as a greater occurrence of neurological conditions, an expanding population of individuals suffering from chronic pain, the increasing uptake of deep brain stimulation treatments, the proliferation of specialized neurology centers, and a growing body of clinical evidence supporting neuromodulation techniques.
The neural implants market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $9.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. Key drivers for this growth during the forecast period include progress in implantable neurotechnology, an expanding elderly demographic experiencing neurological disorders, an increasing need for tailored neurology treatments, the proliferation of outpatient neurological procedures, and enhanced investment in neurotechnology research. Significant trends expected during this period involve the increasing embrace of neurostimulation therapies for chronic ailments, greater utilization of implantable devices for movement-related conditions, wider clinical acceptance of brain-computer interface technologies, the broadening of neuromodulation’s utility beyond pain relief, and a surging requirement for prolonged neurological disorder management solutions.
Get A Free Sample Report With In-Depth Market Insights:
Neural Implants Market Demand Drivers: What’s Powering Industry Growth?
The increasing occurrence of neurological disorders is anticipated to stimulate the expansion of the neural implants market in the future. A neurological disorder is defined as any condition of the nervous system characterized by anatomical, biochemical, or electrical irregularities in the brain, spinal cord, or peripheral nerves. The rise in these disorders stems from several factors, including aging populations, genetic predispositions, and shifts in diagnostic criteria. Neural implants address and control various neurological diseases by directly interacting with the nervous system to regain or improve nervous system capabilities. These implants offer a customized solution, which can enhance treatment effectiveness while minimizing side effects, especially for conditions like Parkinson’s disease, epilepsy, and spinal cord injuries. As an illustration, in 2024, according to the Department of Health and Human Services, a US-based federal cabinet-level department that protects the health and well-being of Americans through various programs, in 2023, more than 6 million Americans were living with Alzheimer’s disease, and forecasts project that this number will increase significantly each year as the population ages, reaching 13 million by 2060. Consequently, the growing prevalence of neurological disorders is fueling the growth of the neural implants market.
Neural Implants Market Segment Outlook: Which Categories Are Growing Fastest?
The neural implants market covered in this report is segmented –
1) By Product: F And B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)
2) By Application: Chronic Pain, Parkinson’s Disease (PD), Epilepsy, Other Applications
3) By End-User: Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers
Subsegments:
1) By F And B Spinal Cord Stimulation (SCS): Traditional Spinal Cord Stimulation, High-Frequency Spinal Cord Stimulation, Burst Spinal Cord Stimulation
2) By Deep Brain Stimulation (DBS): Subthalamic Nucleus (Stn) Dbs, Globus Pallidus Internus (Gpi) Dbs, Ventral Intermediate Nucleus (Vim) Dbs
3) By Vagus Nerve Stimulation (VNS): Implantable Vagus Nerve Stimulators, Non-Invasive Vagus Nerve Stimulators
Neural Implants Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies in the neural implant market are concentrating on developing innovative products, such as deep brain stimulation (DBS) devices, to treat movement disorders like Parkinson’s disease and essential tremors, aiming to gain a competitive advantage. Deep Brain Stimulation (DBS) devices are medical implants designed to treat neurological disorders by delivering electrical impulses to specific brain areas. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and healthcare company, launched Liberta RC, which is the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to assist individuals living with movement disorders. It boasts the fewest recharges of any FDA-approved DBS system, requiring only 10 recharge sessions per year for the majority of users. This product integrates with Abbott’s proprietary NeuroSphere virtual clinic, allowing customers to communicate with clinicians, confirm proper settings and functionality, and receive updated treatment settings remotely. The system utilizes a wireless charger that can be placed over the product, enabling users to remain active while wearing it. Additionally, the device provides customers with useful notifications and customized settings to ensure a personalized charging experience.
Neural Implants Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the neural implants market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Nevro Corp., NeuroPace Inc., Axonics Modulation Technologies Inc., Saluda Medical, Nuvectra Corporation, Cerbomed GmbH, Inspire Medical Systems Inc., Synchron Inc., Blackrock Neurotech, Neuralink, BrainGate, Bioinduction Ltd, SetPoint Medical, CereGate, Gyrus ACMI, Aleva Neurotherapeutics
View The Full Neural Implants Market Report:
Neural Implants Market Geographic Spread And Regional Opportunities
North America was the largest region in the neural implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neural implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
